Return On Capital Employed Overview: Amgen

Looking at Q1, Amgen (NASDAQ:AMGN) earned $2.13 billion, a 6.03% increase from the preceding quarter. Amgen’s sales decreased to $5.90 billion, a 11.05% change since Q4. In Q4…